Orthogen: Developing the Future of Medical Technology

Logo

Springfield, NJ -- (SBWire) -- 07/06/2016 --In recent years, dental professionals have treated to a number of new and exciting technologies that allow them to improve the standards of patient care. Dental bone grafting materials like DentoGen and NanoGen have markedly increased the success of site grafts. These technologies and others have propelled oral surgery into the 21st century.

Orthogen, developers of both NanoGen and DentoGen have done work in areas besides bone grafts. In addition to their line of dental instruments, the company's Research and Development department was awarded a $500,000 grant from the Small Business Technology Transfer Program of the National Institutes of Health for research in limb prosthesis. The results of their research was eye-opening.

There are nearly two million American amputees. The technology to aid those amputees in their daily tasks has grown by leaps and bounds in the past two decades, but there is still a good amount of work to be done before these men and women can function like they did when they had their limbs.

Orthogen developed a peripheral nerve interface to operate prosthetic limbs. The interface connected bone, connective tissue and skin to the surface of a prosthetic. The results of the study were promising, but since the company is focused on developing synthetic bone grafts, the company is searching for partners interested in sub-licensing the technology.

To learn more about Orthogen, the products they have developed or to buy dental bone grafting material online, interested parties are encouraged to visit the website at http://www.orthogencorp.com/.

About Orthogen, LLC
Originally a division of BioLok International, which is now merged with BioHorizons, Orthogen, LLC was established in 2007 to develop and market next generation bone-grafting products for orthopedic and dental applications. Dr. Sachin Mamidwar serves as CEO of the company whereas Dr. Harold Alexander, previously Director of Orthopedic research at the Hospital for Joint Diseases, New York, serves as the Chairman of the Board. Orthogen offers various products including DentoGen®, NanoGen, collagen membranes, related instruments and sutures for dental applications.

To inquire about the company's products and technologies, please call 1-877-336-8643.

Media Relations Contact

Alex Schwartz
http://www.orthogencorp.com/

View this press release online at: http://rwire.com/704283